NC Durham의 유방암 임상 시험
유방암 관련 연구 64개가 Durham 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
A Study of PHST001 in Advanced Solid Tumors
피험자 모집 중1상
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
피험자 모집 중3상
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
피험자 모집 중2상건강한 지원자 환영
- University of North Carolina, Chapel Hill · 10마일 거리
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
피험자 모집 중2상
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
피험자 모집 중관찰 연구
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
피험자 모집 중1상
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
피험자 모집 중관찰 연구건강한 지원자 환영
- University of North Carolina, Chapel Hill · 10마일 거리
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
피험자 모집 중3상
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
피험자 모집 중1상
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- University of North Carolina Medical Center, Chapel Hill · 10마일 거리
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
피험자 모집 중2상
- University of North Carolina Medical Center, Chapel Hill · 10마일 거리
Identifying Patterns in the Breath of Individuals With Breast Cancer
피험자 모집 중관찰 연구건강한 지원자 환영
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
피험자 모집 중2상
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10마일 거리
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
피험자 모집 중2상
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10마일 거리
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
피험자 모집 중관찰 연구
- University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
피험자 모집 중1/2상
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
피험자 모집 중1/2상
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
피험자 모집 중3상
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
피험자 모집 중2상
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
- University of North Carolina-Hillsborough Campus, Hillsborough · 13마일 거리
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
피험자 모집 중건강한 지원자 환영
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
Optimizing Surgical Decisions in Young Adults With Breast Cancer
피험자 모집 중
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
피험자 모집 중관찰 연구
- University of North Carolina, Chapel Hill · 10마일 거리
Weight Management After Cancer for Survivors in Rural Communities
피험자 모집 중
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
피험자 모집 중
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
피험자 모집 중2/3상
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
피험자 모집 중
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
피험자 모집 중2상
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
피험자 모집 중
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
피험자 모집 중1상
- University of North Carolina, Chapel Hill · 10마일 거리
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
피험자 모집 중
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10마일 거리
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
피험자 모집 중
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
피험자 모집 중관찰 연구
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10마일 거리
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
피험자 모집 중3상
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
피험자 모집 중1상
- University of North Carolina, Chapel Hill · 10마일 거리
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
피험자 모집 중2상건강한 지원자 환영
- The University of North Carolina, Chapel Hill · 10마일 거리
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
피험자 모집 중관찰 연구
- University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
피험자 모집 중
- University of North Carolina, Chapel Hill · 10마일 거리
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
피험자 모집 중2상
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10마일 거리
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
피험자 모집 중2상
- The University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
피험자 모집 중2상
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
피험자 모집 중
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
피험자 모집 중1/2상
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
피험자 모집 중관찰 연구
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
피험자 모집 중2상
- University of North Carolina, Chapel Hill · 10마일 거리
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
피험자 모집 중
- UNC Cancer Hospital, Chapel Hill · 10마일 거리
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
피험자 모집 중
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
피험자 모집 중
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
피험자 모집 중
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10마일 거리
BREAST Choice Decision Tool R21 - AIM2
피험자 모집 중건강한 지원자 환영
- The University of North Carolina, Chapel Hill · 10마일 거리
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
피험자 모집 중
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Chapel Hill · 10마일 거리
UNC Pleural Fluid Registry
피험자 모집 중관찰 연구
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10마일 거리
다른 도시의 유방암 시험
- New York City, NY연구 136개
- Houston, TX연구 126개
- Boston, MA연구 112개
- Nashville, TN연구 81개
- Los Angeles, CA연구 73개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Queens, NY연구 64개
- Chicago, IL연구 59개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
- San Antonio, TX연구 47개
Durham의 다른 연구
- 암 (전체)연구 58개
- 비소세포폐암연구 39개
- 다발성 골수종연구 37개
- 급성 골수성 백혈병연구 33개
- 전이성 암연구 33개
- 전립선암연구 32개
- 폐암연구 32개
- 대장직장암연구 28개
- 난소암연구 27개
- 만성 림프구성 백혈병연구 27개
- 심부전연구 26개
- 췌장암연구 24개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.